Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te (Q36855581)
Jump to navigation
Jump to search
scientific article published on February 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te |
scientific article published on February 1997 |
Statements
1 reference
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te (English)
1 reference
Odds FC
1 reference
Barry AL
1 reference
Pfaller MA
1 reference
Rex JH
1 reference
Galgiani JN
1 reference
Bartlett MS
1 reference
Espinel-Ingroff A
1 reference
Ghannoum MA
1 reference
Lancaster M
1 reference
Rinaldi MG
1 reference
Walsh TJ
1 reference
1 February 1997
1 reference
1 reference
Identifiers
1 reference